Johnson & Johnson Q3 FY25: where the revenue came from and where it went
The whole income statement of Johnson & Johnson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 30 – Sep 28, 2025
- Reported
- Oct 22, 2025
Revenue$24.0B
+7% year over year
Gross profit$16.7B
70% margin
Operating profit$7.1B
30% margin
Net profit$5.2B
21% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 24.0 | 100% | +7% |
| Innovative medicine | 15.6 | 65% | +7% |
| Med tech | 8.4 | 35% | +7% |
| Cost of revenue | −7.3 | 30% | |
| Gross profit | 16.7 | 70% margin | +1pp |
| SG&A | −5.9 | 25% | +0pp |
| Other | −3.7 | 15% | +0pp |
| Operating profit | 7.1 | 30% margin | +0pp |
| Other income, net | 0.4 | ||
| Tax | −2.3 | ||
| Net profit | 5.2 | 21% margin | +9pp |
304 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest